✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Albert David Ltd.

ALBERTDAVD

Market Cap
₹504 Cr.
P/E
29.30

Albert David Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
504 Cr
PE
PE
29.30
Prom Holding
Prom Holding
62.24 %
ROE (%)
ROE (%)
19.69
ROCE (%)
ROCE (%)
24.49
Div Yield (%)
Div Yield (%)
1.87
Sales
Sales
345 Cr
OPM (%)
OPM (%)
0.88 %
Debt to Equity
Debt to Equity
0.01
View more
Edit Ratio's
About
Albert David Limited (ADL) is a leading drug manufacturer based in Kolkata, India, specializin… Read more
Low
764
52W Range
High
1753
  • Albert David
  • Brooks Laboratories
  • Lyka Labs
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Dosage Form Break-Up

Customer Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Customers
    • Government
    FAQs on Albert David Ltd. Business

    Albert David Limited, a leading Indian drug manufacturer based in Kolkata, offers a wide range of pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and medical disposables. It is a key subsidiary of the Kothari Group, known for its advanced R&D and manufacturing capabilities.

    Albert David major competitors are Brooks Laboratories, Zim Laboratories, Lyka Labs, Medicamen Biotech, Prevest Denpro, Fredun Pharma, Jenburkt Pharma.
    Market Cap of Albert David is ₹477 Crs.
    While the median market cap of its peers are ₹545 Crs.

    Albert David seems to be less financially stable compared to its competitors.
    Altman Z score of Albert David is 3.21 and is ranked 7 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Albert David Ltd.
    View the discussion on ValuePickr
    How This Company Is Manipulating Its Cash From Operations - Dr Vijay Malik
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material